This document describes a method for estimating the amount of bilirubin in serum. It begins with an introduction to bilirubin, its metabolism, and types of jaundice. It then discusses pre-hepatic, hepatic, and post-hepatic jaundice and their causes. The principle section notes that direct bilirubin reacts easily with reagents while indirect bilirubin requires a solubilizing agent. The method section provides steps to estimate direct and total bilirubin levels in serum samples. Calculations are presented to determine concentrations of direct and total bilirubin from absorbance readings.
This document discusses hemoglobin and bilirubin metabolism. It describes how bilirubin is formed from the breakdown of heme in red blood cells by heme oxygenase. Bilirubin is conjugated in the liver by UDP-glucuronyltransferase and excreted in bile or urine. Jaundice can result from hemolytic, hepatic, or obstructive causes that increase bilirubin levels. Neonatal jaundice is also discussed, which can cause kernicterus if bilirubin levels become too high.
This document discusses hemoglobin and bilirubin metabolism. It describes how bilirubin is formed from the breakdown of heme in red blood cells by heme oxygenase. Bilirubin is conjugated in the liver by UDP-glucuronyltransferase and excreted in bile or urine. Jaundice can result from hemolytic, hepatic, or obstructive causes that increase bilirubin levels. Neonatal jaundice is also discussed, which can cause kernicterus if bilirubin levels become too high. The document provides details on different hyperbilirubinemias and tests used to diagnose the type of jaundice.
- Erythrocytes have a lifespan of 120 days in adults before being degraded by macrophages in the spleen and liver.
- Haemoglobin is degraded into its protein (globin) and non-protein (heme) components. About 6 g of haemoglobin is broken down per day in adults.
- Globin can be reutilized for new haemoglobin or degraded into individual amino acids. Heme is broken down by heme oxygenase into iron, carbon monoxide, and biliverdin which is further degraded into bilirubin. Bilirubin is conjugated in the liver and excreted into bile.
Bilirubin is produced from the breakdown of heme in red blood cells. It travels to the liver where it is conjugated and excreted in bile. Elevated bilirubin levels can indicate liver dysfunction or bile duct obstruction. Neonatal jaundice is common and results from the immature liver's limited ability to conjugate bilirubin for excretion. Bilirubin levels must be monitored closely in newborns to prevent brain damage from hyperbilirubinemia.
The document summarizes heme catabolism and bilirubin metabolism. It discusses the three stages of heme degradation: formation of bilirubin in the reticuloendothelial system, uptake and conjugation of bilirubin in the liver, and catabolism of bilirubin in the gut. It also describes different types of hyperbilirubinemia and jaundice, including physiological, genetic causes like Gilbert's syndrome, and obstructive jaundice.
What is the Difference Between Conjugated and Unconjugated Bilirubin?Sumit Sharma
Bilirubin is a biochemical parameter of your liver function test. Your doctor uses this tool to diagnose liver disease.
In the human body, bilirubin is a waste product of your hemoglobin produced during the red blood cells breakdown in the spleen.
Although bilirubin does not have a specific function, it is generally a component of bile juice. It is also called a bile pigment, which is yellow in color.
There are two forms of bilirubin in our blood.
One is unconjugated bilirubin, which forms during the breakdown of red blood cells, and the other is conjugated, which starts during metabolism in the liver.
The unconjugated bilirubin is a catabolic product of red blood cells. This non-conjugated compound is also known as indirect bilirubin.
Some possible reasons or diseases associated with unconjugated hyperbilirubinemia –
1. Hemolytic anemia
2. Neonatal Jaundice
3. Genetic factors
4. Drug induced unconjugated hyperbilirubinemia
On the other hands, Conjugated bilirubin is generally formed after the glucuronidation of the unconjugated bilirubin.
The conjugation process occurs in your liver and converts your unconjugated bilirubin into conjugated bilirubin. This type of glucuronidation compound is also known as direct bilirubin.
In simple words, direct bilirubin means conjugated bilirubin.
The elevated conjugated bilirubin indicates Conjugated hyperbilirubinemia.
This condition is most commonly seen in cholestatic liver disease.
Cholestatic is a medical condition where the flow of bile juice gets reduced or stopped. You may have this cholestatic liver disease in two forms – Intrahepatic and extrahepatic obstruction.
In this article, we will discuss bilirubin, metabolism of bilirubin, normal range of bilirubin, and its clinical relevance. Further, we will also know the difference between conjugated and unconjugated bilirubin.
Total bilirubin is a breakdown product of heme from hemoglobin in red blood cells. It is responsible for jaundice when levels are elevated. Bilirubin is produced through the breakdown of hemoglobin by macrophages and hepatocytes. It is excreted in bile after being conjugated by the liver and later broken down by gut bacteria. Elevations can occur from hemolysis, liver disease, or cholestasis. Measurement of conjugated versus unconjugated bilirubin can help determine the underlying cause.
This document discusses hemoglobin and bilirubin metabolism. It describes how bilirubin is formed from the breakdown of heme in red blood cells by heme oxygenase. Bilirubin is conjugated in the liver by UDP-glucuronyltransferase and excreted in bile or urine. Jaundice can result from hemolytic, hepatic, or obstructive causes that increase bilirubin levels. Neonatal jaundice is also discussed, which can cause kernicterus if bilirubin levels become too high.
This document discusses hemoglobin and bilirubin metabolism. It describes how bilirubin is formed from the breakdown of heme in red blood cells by heme oxygenase. Bilirubin is conjugated in the liver by UDP-glucuronyltransferase and excreted in bile or urine. Jaundice can result from hemolytic, hepatic, or obstructive causes that increase bilirubin levels. Neonatal jaundice is also discussed, which can cause kernicterus if bilirubin levels become too high. The document provides details on different hyperbilirubinemias and tests used to diagnose the type of jaundice.
- Erythrocytes have a lifespan of 120 days in adults before being degraded by macrophages in the spleen and liver.
- Haemoglobin is degraded into its protein (globin) and non-protein (heme) components. About 6 g of haemoglobin is broken down per day in adults.
- Globin can be reutilized for new haemoglobin or degraded into individual amino acids. Heme is broken down by heme oxygenase into iron, carbon monoxide, and biliverdin which is further degraded into bilirubin. Bilirubin is conjugated in the liver and excreted into bile.
Bilirubin is produced from the breakdown of heme in red blood cells. It travels to the liver where it is conjugated and excreted in bile. Elevated bilirubin levels can indicate liver dysfunction or bile duct obstruction. Neonatal jaundice is common and results from the immature liver's limited ability to conjugate bilirubin for excretion. Bilirubin levels must be monitored closely in newborns to prevent brain damage from hyperbilirubinemia.
The document summarizes heme catabolism and bilirubin metabolism. It discusses the three stages of heme degradation: formation of bilirubin in the reticuloendothelial system, uptake and conjugation of bilirubin in the liver, and catabolism of bilirubin in the gut. It also describes different types of hyperbilirubinemia and jaundice, including physiological, genetic causes like Gilbert's syndrome, and obstructive jaundice.
What is the Difference Between Conjugated and Unconjugated Bilirubin?Sumit Sharma
Bilirubin is a biochemical parameter of your liver function test. Your doctor uses this tool to diagnose liver disease.
In the human body, bilirubin is a waste product of your hemoglobin produced during the red blood cells breakdown in the spleen.
Although bilirubin does not have a specific function, it is generally a component of bile juice. It is also called a bile pigment, which is yellow in color.
There are two forms of bilirubin in our blood.
One is unconjugated bilirubin, which forms during the breakdown of red blood cells, and the other is conjugated, which starts during metabolism in the liver.
The unconjugated bilirubin is a catabolic product of red blood cells. This non-conjugated compound is also known as indirect bilirubin.
Some possible reasons or diseases associated with unconjugated hyperbilirubinemia –
1. Hemolytic anemia
2. Neonatal Jaundice
3. Genetic factors
4. Drug induced unconjugated hyperbilirubinemia
On the other hands, Conjugated bilirubin is generally formed after the glucuronidation of the unconjugated bilirubin.
The conjugation process occurs in your liver and converts your unconjugated bilirubin into conjugated bilirubin. This type of glucuronidation compound is also known as direct bilirubin.
In simple words, direct bilirubin means conjugated bilirubin.
The elevated conjugated bilirubin indicates Conjugated hyperbilirubinemia.
This condition is most commonly seen in cholestatic liver disease.
Cholestatic is a medical condition where the flow of bile juice gets reduced or stopped. You may have this cholestatic liver disease in two forms – Intrahepatic and extrahepatic obstruction.
In this article, we will discuss bilirubin, metabolism of bilirubin, normal range of bilirubin, and its clinical relevance. Further, we will also know the difference between conjugated and unconjugated bilirubin.
Total bilirubin is a breakdown product of heme from hemoglobin in red blood cells. It is responsible for jaundice when levels are elevated. Bilirubin is produced through the breakdown of hemoglobin by macrophages and hepatocytes. It is excreted in bile after being conjugated by the liver and later broken down by gut bacteria. Elevations can occur from hemolysis, liver disease, or cholestasis. Measurement of conjugated versus unconjugated bilirubin can help determine the underlying cause.
This document discusses hyperbilirubinemia and jaundice. It defines bilirubin and explains how it is formed from the breakdown of hemoglobin and transported to the liver. It describes the different types of bilirubin and the process of conjugation. It then defines and describes the causes and symptoms of prehepatic (hemolytic), intrahepatic (hepatic), and obstructive (post-hepatic) jaundice. Key tests for differentiating the types of jaundice are provided along with normal bilirubin levels and implications of elevated levels.
Jaundice, also known as icterus, is a liver disease characterized by elevated bilirubin levels in the blood. It occurs when bilirubin levels exceed 2mg/dl. There are three main types - prehepatic, intrahepatic, and posthepatic - depending on where the blockage of bilirubin occurs. Signs and symptoms include yellowing of the skin and eyes. Diagnosis involves medical history, physical exam, urine and blood tests, and imaging. Treatment depends on the underlying cause but may include phototherapy, medications to improve bilirubin clearance or surgery to unblock bile ducts. Prevention focuses on limiting potential liver toxins and maintaining vaccination against hepatitis viruses
It is characterized by a yellow appearance of the (1) Skin (2) Mucous membranes and (3) Sclera caused by bilirubin deposition. It is the most specific clinical manifestation of Hepatic dysfunction.
Jaundice is usually present clinically when the plasma bilirubin concentration reaches 2 to 3 mg/dl.
When bilirubin clearance from the Liver to the Intestinal tract is impaired (as in acute hepatitis and bile duct obstruction) it may be accompanied by alcoholic (Gray coloured) stools.Solubility increases in water , soluble conjugated bilirubin leads to Tea coloured urine.
This document summarizes key aspects of jaundice and bilirubin metabolism. It discusses how bilirubin is produced from the breakdown of heme in senescent red blood cells, transported to the liver bound to albumin, and processed in the liver through conjugation and excretion. It describes the normal 5 steps of bilirubin metabolism and defines pre-hepatic, hepatic, and post-hepatic causes of jaundice. The document contrasts the pathophysiology of unconjugated versus conjugated hyperbilirubinemia and outlines clinical features of cholestasis.
1. Hemoglobin is broken down through a series of steps after red blood cells are destroyed. This produces the yellow pigment bilirubin.
2. Jaundice occurs when bilirubin levels in the blood rise above normal. It can be caused by increased red blood cell breakdown, liver problems filtering bilirubin, or blockages in the bile ducts.
3. There are three main types of jaundice - pre-hepatic from too much red blood cell breakdown, hepatic from liver issues, and post-hepatic from bile duct blockages. They are distinguished by urine/stool pigments and liver function test results.
A bilirubin test measures the levels of bilirubin in the blood, which is produced during the breakdown of red blood cells and processed by the liver. Higher bilirubin levels can indicate liver or bile duct problems or increased red blood cell destruction. Bilirubin testing is usually done as part of a group of liver function tests to investigate jaundice, determine possible bile duct blockages, detect or monitor liver disease, evaluate anemia, and follow treatment effectiveness or potential drug toxicity. Common related tests include liver function tests, albumin and total protein levels, complete blood counts, and prothrombin time.
The document summarizes information about liver function tests and bilirubin metabolism. It discusses:
- Liver function tests measure enzyme and protein levels to evaluate liver health and function. They can screen for disease, determine disease patterns, and assess severity and treatment response.
- Bilirubin is produced from the breakdown of heme in red blood cells. The liver conjugates bilirubin so it can be excreted in bile or urine. Elevated bilirubin levels can indicate liver damage or blockages.
- Tests are classified based on the liver's excretory, detoxification, synthetic and metabolic functions. Enzymes like AST, ALT and GGT are also measured
The document discusses liver function tests and bilirubin metabolism. It describes that liver function tests are useful for diagnosing and monitoring liver diseases. A battery of tests are needed since the liver has diverse functions including excretion, metabolism, protein and plasma synthesis, and storage. Specific tests mentioned include liver enzymes, albumin, prothrombin time, tumor markers, bilirubin, and dye excretion tests. The types of jaundice - hemolytic, obstructive, and hepatic - are distinguished based on conjugated and unconjugated bilirubin levels as well as other factors. Various inborn errors affecting bilirubin metabolism are also outlined.
The document summarizes the process of hemoglobin degradation and bilirubin metabolism. It discusses how hemoglobin is broken down into globin, heme, and iron. Heme is further degraded into biliverdin and then bilirubin by heme oxygenase. Bilirubin is conjugated in the liver and secreted into bile. It is excreted in feces or reabsorbed and appears in urine. Conditions that interfere with bilirubin metabolism can cause jaundice. The document classifies types of jaundice and inherited disorders of bilirubin metabolism.
This document summarizes jaundice and hyperbilirubinemia. It describes how jaundice results from the deposition of bilirubin in tissues due to high bilirubin levels in the blood. Bilirubin levels can be estimated by examining the skin and mucous membranes for a yellow color. Higher bilirubin levels result in darker urine. The document then discusses the production, metabolism, and excretion of bilirubin, how liver disease or other issues can cause hyperbilirubinemia, and how to evaluate patients with jaundice.
The major points of heme catabolism and bilirubin metabolism are:
1. Heme is broken down to bilirubin in macrophages of the reticuloendothelial system, mainly in the liver and spleen.
2. Unconjugated bilirubin is transported to the liver bound to albumin and taken up by hepatocytes.
3. In hepatocytes, bilirubin is conjugated with glucuronic acid and secreted into bile.
4. In the intestines, bilirubin is converted to urobilinogen and a portion reabsorbed, becoming excreted in urine as urobilin, while the remainder is oxidized to st
This document discusses bilirubin metabolism and jaundice. It begins by explaining bilirubin formation from heme and its transport and metabolism in the liver, which involves hepatic uptake, conjugation, and biliary excretion. An enterohepatic circulation is also described. Jaundice occurs when bilirubin levels exceed 2 mg/dL and can be pre-hepatic (hemolytic), hepatic, or obstructive in origin. Specific causes and characteristics of each jaundice type are provided. The document also discusses hyperbilirubinemia conditions like Gilbert's syndrome and Crigler-Najjar syndrome. Testing to differentiate jaundice types and clinical features like symptoms and lab findings are summarized
The document discusses liver function tests (LFTs). It begins by providing an overview of liver anatomy and functions. Key points include that the liver is the largest organ and performs many metabolic and excretory roles. LFTs evaluate the liver's functioning in these roles. The document then examines specific LFTs in detail, grouping them into those related to pigment metabolism, carbohydrate metabolism, plasma proteins, lipids, detoxification, excretion, blood clotting factors, blood ammonia, and serum enzymes. Elevations in different enzymes and analytes provide clues to conditions like hepatitis, cirrhosis, or obstruction. The tests discussed provide insights into liver health and disease.
1) Hemoglobin is broken down in red blood cells, producing bilirubin at a rate of approximately 250-350 mg per day.
2) Bilirubin binds to albumin and is transported to the liver, where it is conjugated and secreted into bile ducts.
3) Jaundice occurs when there is excessive bilirubin that cannot be processed by the liver, resulting in a buildup that discolors the skin and eyes. It can be caused by hemolytic anemia, liver disease, or bile duct obstruction.
The document provides information about liver function tests and bilirubin metabolism. It discusses that liver function tests measure enzymes and proteins to evaluate how well the liver is performing its normal functions. Bilirubin is produced from the breakdown of heme in red blood cells and is metabolized and excreted by the liver. Elevations in bilirubin or certain enzymes in the blood can indicate liver disease or damage. Tests of bilirubin, enzymes, bile salts, and other substances in blood and urine are used to evaluate liver function and diagnose liver conditions.
Jaundice, or icterus, is caused by the deposition of bilirubin in tissues resulting in a yellowish discoloration. Bilirubin deposition only occurs with hyperbilirubinemia and indicates either liver disease or a hemolytic disorder. Slight increases in bilirubin are best detected by examining the sclerae, which have an affinity for bilirubin. Bilirubin is produced from the breakdown of hemoglobin and transported bound to albumin to the liver where it is conjugated and excreted in bile and ultimately in feces. Laboratory tests are used to evaluate jaundice and determine if the cause is pre-hepatic, hepatocellular
The document discusses various liver function tests that can help evaluate liver health. Tests that detect liver cell injury include alanine transaminase (ALT) and aspartate transaminase (AST), which are released when the liver cell membrane is damaged. Elevated levels of these enzymes suggest hepatocellular damage. Tests that indicate cholestasis and obstruction of bile flow include alkaline phosphatase, 5' nucleotidase, and leucine aminopeptidase. The ratio of AST to ALT can help differentiate conditions such as alcoholic liver disease. Together these tests provide insight into liver synthetic, metabolic and detoxification functions.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
This document discusses hyperbilirubinemia and jaundice. It defines bilirubin and explains how it is formed from the breakdown of hemoglobin and transported to the liver. It describes the different types of bilirubin and the process of conjugation. It then defines and describes the causes and symptoms of prehepatic (hemolytic), intrahepatic (hepatic), and obstructive (post-hepatic) jaundice. Key tests for differentiating the types of jaundice are provided along with normal bilirubin levels and implications of elevated levels.
Jaundice, also known as icterus, is a liver disease characterized by elevated bilirubin levels in the blood. It occurs when bilirubin levels exceed 2mg/dl. There are three main types - prehepatic, intrahepatic, and posthepatic - depending on where the blockage of bilirubin occurs. Signs and symptoms include yellowing of the skin and eyes. Diagnosis involves medical history, physical exam, urine and blood tests, and imaging. Treatment depends on the underlying cause but may include phototherapy, medications to improve bilirubin clearance or surgery to unblock bile ducts. Prevention focuses on limiting potential liver toxins and maintaining vaccination against hepatitis viruses
It is characterized by a yellow appearance of the (1) Skin (2) Mucous membranes and (3) Sclera caused by bilirubin deposition. It is the most specific clinical manifestation of Hepatic dysfunction.
Jaundice is usually present clinically when the plasma bilirubin concentration reaches 2 to 3 mg/dl.
When bilirubin clearance from the Liver to the Intestinal tract is impaired (as in acute hepatitis and bile duct obstruction) it may be accompanied by alcoholic (Gray coloured) stools.Solubility increases in water , soluble conjugated bilirubin leads to Tea coloured urine.
This document summarizes key aspects of jaundice and bilirubin metabolism. It discusses how bilirubin is produced from the breakdown of heme in senescent red blood cells, transported to the liver bound to albumin, and processed in the liver through conjugation and excretion. It describes the normal 5 steps of bilirubin metabolism and defines pre-hepatic, hepatic, and post-hepatic causes of jaundice. The document contrasts the pathophysiology of unconjugated versus conjugated hyperbilirubinemia and outlines clinical features of cholestasis.
1. Hemoglobin is broken down through a series of steps after red blood cells are destroyed. This produces the yellow pigment bilirubin.
2. Jaundice occurs when bilirubin levels in the blood rise above normal. It can be caused by increased red blood cell breakdown, liver problems filtering bilirubin, or blockages in the bile ducts.
3. There are three main types of jaundice - pre-hepatic from too much red blood cell breakdown, hepatic from liver issues, and post-hepatic from bile duct blockages. They are distinguished by urine/stool pigments and liver function test results.
A bilirubin test measures the levels of bilirubin in the blood, which is produced during the breakdown of red blood cells and processed by the liver. Higher bilirubin levels can indicate liver or bile duct problems or increased red blood cell destruction. Bilirubin testing is usually done as part of a group of liver function tests to investigate jaundice, determine possible bile duct blockages, detect or monitor liver disease, evaluate anemia, and follow treatment effectiveness or potential drug toxicity. Common related tests include liver function tests, albumin and total protein levels, complete blood counts, and prothrombin time.
The document summarizes information about liver function tests and bilirubin metabolism. It discusses:
- Liver function tests measure enzyme and protein levels to evaluate liver health and function. They can screen for disease, determine disease patterns, and assess severity and treatment response.
- Bilirubin is produced from the breakdown of heme in red blood cells. The liver conjugates bilirubin so it can be excreted in bile or urine. Elevated bilirubin levels can indicate liver damage or blockages.
- Tests are classified based on the liver's excretory, detoxification, synthetic and metabolic functions. Enzymes like AST, ALT and GGT are also measured
The document discusses liver function tests and bilirubin metabolism. It describes that liver function tests are useful for diagnosing and monitoring liver diseases. A battery of tests are needed since the liver has diverse functions including excretion, metabolism, protein and plasma synthesis, and storage. Specific tests mentioned include liver enzymes, albumin, prothrombin time, tumor markers, bilirubin, and dye excretion tests. The types of jaundice - hemolytic, obstructive, and hepatic - are distinguished based on conjugated and unconjugated bilirubin levels as well as other factors. Various inborn errors affecting bilirubin metabolism are also outlined.
The document summarizes the process of hemoglobin degradation and bilirubin metabolism. It discusses how hemoglobin is broken down into globin, heme, and iron. Heme is further degraded into biliverdin and then bilirubin by heme oxygenase. Bilirubin is conjugated in the liver and secreted into bile. It is excreted in feces or reabsorbed and appears in urine. Conditions that interfere with bilirubin metabolism can cause jaundice. The document classifies types of jaundice and inherited disorders of bilirubin metabolism.
This document summarizes jaundice and hyperbilirubinemia. It describes how jaundice results from the deposition of bilirubin in tissues due to high bilirubin levels in the blood. Bilirubin levels can be estimated by examining the skin and mucous membranes for a yellow color. Higher bilirubin levels result in darker urine. The document then discusses the production, metabolism, and excretion of bilirubin, how liver disease or other issues can cause hyperbilirubinemia, and how to evaluate patients with jaundice.
The major points of heme catabolism and bilirubin metabolism are:
1. Heme is broken down to bilirubin in macrophages of the reticuloendothelial system, mainly in the liver and spleen.
2. Unconjugated bilirubin is transported to the liver bound to albumin and taken up by hepatocytes.
3. In hepatocytes, bilirubin is conjugated with glucuronic acid and secreted into bile.
4. In the intestines, bilirubin is converted to urobilinogen and a portion reabsorbed, becoming excreted in urine as urobilin, while the remainder is oxidized to st
This document discusses bilirubin metabolism and jaundice. It begins by explaining bilirubin formation from heme and its transport and metabolism in the liver, which involves hepatic uptake, conjugation, and biliary excretion. An enterohepatic circulation is also described. Jaundice occurs when bilirubin levels exceed 2 mg/dL and can be pre-hepatic (hemolytic), hepatic, or obstructive in origin. Specific causes and characteristics of each jaundice type are provided. The document also discusses hyperbilirubinemia conditions like Gilbert's syndrome and Crigler-Najjar syndrome. Testing to differentiate jaundice types and clinical features like symptoms and lab findings are summarized
The document discusses liver function tests (LFTs). It begins by providing an overview of liver anatomy and functions. Key points include that the liver is the largest organ and performs many metabolic and excretory roles. LFTs evaluate the liver's functioning in these roles. The document then examines specific LFTs in detail, grouping them into those related to pigment metabolism, carbohydrate metabolism, plasma proteins, lipids, detoxification, excretion, blood clotting factors, blood ammonia, and serum enzymes. Elevations in different enzymes and analytes provide clues to conditions like hepatitis, cirrhosis, or obstruction. The tests discussed provide insights into liver health and disease.
1) Hemoglobin is broken down in red blood cells, producing bilirubin at a rate of approximately 250-350 mg per day.
2) Bilirubin binds to albumin and is transported to the liver, where it is conjugated and secreted into bile ducts.
3) Jaundice occurs when there is excessive bilirubin that cannot be processed by the liver, resulting in a buildup that discolors the skin and eyes. It can be caused by hemolytic anemia, liver disease, or bile duct obstruction.
The document provides information about liver function tests and bilirubin metabolism. It discusses that liver function tests measure enzymes and proteins to evaluate how well the liver is performing its normal functions. Bilirubin is produced from the breakdown of heme in red blood cells and is metabolized and excreted by the liver. Elevations in bilirubin or certain enzymes in the blood can indicate liver disease or damage. Tests of bilirubin, enzymes, bile salts, and other substances in blood and urine are used to evaluate liver function and diagnose liver conditions.
Jaundice, or icterus, is caused by the deposition of bilirubin in tissues resulting in a yellowish discoloration. Bilirubin deposition only occurs with hyperbilirubinemia and indicates either liver disease or a hemolytic disorder. Slight increases in bilirubin are best detected by examining the sclerae, which have an affinity for bilirubin. Bilirubin is produced from the breakdown of hemoglobin and transported bound to albumin to the liver where it is conjugated and excreted in bile and ultimately in feces. Laboratory tests are used to evaluate jaundice and determine if the cause is pre-hepatic, hepatocellular
The document discusses various liver function tests that can help evaluate liver health. Tests that detect liver cell injury include alanine transaminase (ALT) and aspartate transaminase (AST), which are released when the liver cell membrane is damaged. Elevated levels of these enzymes suggest hepatocellular damage. Tests that indicate cholestasis and obstruction of bile flow include alkaline phosphatase, 5' nucleotidase, and leucine aminopeptidase. The ratio of AST to ALT can help differentiate conditions such as alcoholic liver disease. Together these tests provide insight into liver synthetic, metabolic and detoxification functions.
Cell Therapy Expansion and Challenges in Autoimmune DiseaseHealth Advances
There is increasing confidence that cell therapies will soon play a role in the treatment of autoimmune disorders, but the extent of this impact remains to be seen. Early readouts on autologous CAR-Ts in lupus are encouraging, but manufacturing and cost limitations are likely to restrict access to highly refractory patients. Allogeneic CAR-Ts have the potential to broaden access to earlier lines of treatment due to their inherent cost benefits, however they will need to demonstrate comparable or improved efficacy to established modalities.
In addition to infrastructure and capacity constraints, CAR-Ts face a very different risk-benefit dynamic in autoimmune compared to oncology, highlighting the need for tolerable therapies with low adverse event risk. CAR-NK and Treg-based therapies are also being developed in certain autoimmune disorders and may demonstrate favorable safety profiles. Several novel non-cell therapies such as bispecific antibodies, nanobodies, and RNAi drugs, may also offer future alternative competitive solutions with variable value propositions.
Widespread adoption of cell therapies will not only require strong efficacy and safety data, but also adapted pricing and access strategies. At oncology-based price points, CAR-Ts are unlikely to achieve broad market access in autoimmune disorders, with eligible patient populations that are potentially orders of magnitude greater than the number of currently addressable cancer patients. Developers have made strides towards reducing cell therapy COGS while improving manufacturing efficiency, but payors will inevitably restrict access until more sustainable pricing is achieved.
Despite these headwinds, industry leaders and investors remain confident that cell therapies are poised to address significant unmet need in patients suffering from autoimmune disorders. However, the extent of this impact on the treatment landscape remains to be seen, as the industry rapidly approaches an inflection point.
Integrating Ayurveda into Parkinson’s Management: A Holistic ApproachAyurveda ForAll
Explore the benefits of combining Ayurveda with conventional Parkinson's treatments. Learn how a holistic approach can manage symptoms, enhance well-being, and balance body energies. Discover the steps to safely integrate Ayurvedic practices into your Parkinson’s care plan, including expert guidance on diet, herbal remedies, and lifestyle modifications.
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd...Donc Test
TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version TEST BANK For Community and Public Health Nursing: Evidence for Practice, 3rd Edition by DeMarco, Walsh, Verified Chapters 1 - 25, Complete Newest Version Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Study Guide Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Stuvia Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Test Bank For Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Pdf Download Course Hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Answers Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Ebook Download Course hero Community and Public Health Nursing: Evidence for Practice 3rd Edition Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Chapters Download Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Pdf Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Study Guide Questions and Answers Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Ebook Download Stuvia Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Questions Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Studocu Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Quizlet Community and Public Health Nursing: Evidence for Practice 3rd Edition Test Bank Stuvia
Osteoporosis - Definition , Evaluation and Management .pdfJim Jacob Roy
Osteoporosis is an increasing cause of morbidity among the elderly.
In this document , a brief outline of osteoporosis is given , including the risk factors of osteoporosis fractures , the indications for testing bone mineral density and the management of osteoporosis
- Video recording of this lecture in English language: https://youtu.be/kqbnxVAZs-0
- Video recording of this lecture in Arabic language: https://youtu.be/SINlygW1Mpc
- Link to download the book free: https://nephrotube.blogspot.com/p/nephrotube-nephrology-books.html
- Link to NephroTube website: www.NephroTube.com
- Link to NephroTube social media accounts: https://nephrotube.blogspot.com/p/join-nephrotube-on-social-media.html
These lecture slides, by Dr Sidra Arshad, offer a quick overview of the physiological basis of a normal electrocardiogram.
Learning objectives:
1. Define an electrocardiogram (ECG) and electrocardiography
2. Describe how dipoles generated by the heart produce the waveforms of the ECG
3. Describe the components of a normal electrocardiogram of a typical bipolar lead (limb II)
4. Differentiate between intervals and segments
5. Enlist some common indications for obtaining an ECG
6. Describe the flow of current around the heart during the cardiac cycle
7. Discuss the placement and polarity of the leads of electrocardiograph
8. Describe the normal electrocardiograms recorded from the limb leads and explain the physiological basis of the different records that are obtained
9. Define mean electrical vector (axis) of the heart and give the normal range
10. Define the mean QRS vector
11. Describe the axes of leads (hexagonal reference system)
12. Comprehend the vectorial analysis of the normal ECG
13. Determine the mean electrical axis of the ventricular QRS and appreciate the mean axis deviation
14. Explain the concepts of current of injury, J point, and their significance
Study Resources:
1. Chapter 11, Guyton and Hall Textbook of Medical Physiology, 14th edition
2. Chapter 9, Human Physiology - From Cells to Systems, Lauralee Sherwood, 9th edition
3. Chapter 29, Ganong’s Review of Medical Physiology, 26th edition
4. Electrocardiogram, StatPearls - https://www.ncbi.nlm.nih.gov/books/NBK549803/
5. ECG in Medical Practice by ABM Abdullah, 4th edition
6. Chapter 3, Cardiology Explained, https://www.ncbi.nlm.nih.gov/books/NBK2214/
7. ECG Basics, http://www.nataliescasebook.com/tag/e-c-g-basics
Muktapishti is a traditional Ayurvedic preparation made from Shoditha Mukta (Purified Pearl), is believed to help regulate thyroid function and reduce symptoms of hyperthyroidism due to its cooling and balancing properties. Clinical evidence on its efficacy remains limited, necessitating further research to validate its therapeutic benefits.
Our backs are like superheroes, holding us up and helping us move around. But sometimes, even superheroes can get hurt. That’s where slip discs come in.
Does Over-Masturbation Contribute to Chronic Prostatitis.pptxwalterHu5
In some case, your chronic prostatitis may be related to over-masturbation. Generally, natural medicine Diuretic and Anti-inflammatory Pill can help mee get a cure.
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by...Donc Test
TEST BANK For Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler, Verified Chapters 1 - 33, Complete Newest Version Community Health Nursing A Canadian Perspective, 5th Edition by Stamler Community Health Nursing A Canadian Perspective, 5th Edition TEST BANK by Stamler Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Study Guide Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Stuvia Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Studocu Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Test Bank For Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Pdf Download Course Hero Community Health Nursing A Canadian Perspective, 5th Edition Answers Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Ebook Download Course hero Community Health Nursing A Canadian Perspective, 5th Edition Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Studocu Community Health Nursing A Canadian Perspective, 5th Edition Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Chapters Download Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Pdf Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Study Guide Questions and Answers Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Ebook Download Stuvia Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Questions Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Studocu Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Quizlet Community Health Nursing A Canadian Perspective, 5th Edition Test Bank Stuvia
6. Types of bilirubin
Direct bilirubin: Conjugated with glucoronic acid
Indirect bilirubin: unconjugated, insoluble in water
Total bilirubin sum of the direct and indirect of
bilirubin.
7. Types of Jaundice
Jaundice is the discoloration of skin and sclera of the eye, which occurs when bilirubin
accumulates in the blood at a level greater than approximately 2.5 mg/dl. Jaundice occurs
because red blood cells are being broken down too fast for the liver to process, because of
disease in the liver, or because of bile duct blockage.
The causes of jaundice may be classified as:
Pre- Hepatic Jaundice
haemolytic disease
Hepatic Jaundice
Cirrhosis of the liver
Infective Hepatitis
Neonatal Jaundice)
Post-Hepatic Jaundice
Cholecystitis.
8. Pre-Hepatic Jaundice
Haemolytic disease
The production of un-conjugated
bilirubin may exceed the conjugating
capacity of the liver and hence the
serum levels of indirect (and of total)
bilirubin will be raised and that of
direct in the upper normal range or
just a little elevated.
The other liver function tests will
usually give normal results
A. Hemolytic anemia
excess
hemolysis
unconjugated bilirubin
(in blood)
upper normal range conjugated
bilirubin (released to bile duct)
9. Hepatic Jaundice
Hepatitis
The conjugative capacity of the liver is approximately normal, but there is the
inability to transport the conjugated bilirubin from the liver cells to the caniculi of the
biliary system, and it will be regurgitated back into the blood. Hence the serum
level of unconjugated bilirubin will be normal, and that of conjugated (and total)
bilirubin will be raised. Synthesizing power is diminished leading to low serum
levels of proteins which are made in the liver and of cholesterol, but the raising of
antibodies to infection usually leads to raised total proteins level.
Cirrhosis (in the absence of infection)
Destruction of liver cells will lead to a reduced conjugating capacity with a raised
serum level of indirect (and of total) bilirubin but with a low level of direct bilirubin
and an abnormally high release, into the blood, of the enzymes: AST, ALT and ALP.
Synthesizing power will be diminished and hence low levels of total protein,
albumin and cholesterol. The insoluble unconjugated bilirubin will not be excreted
in the urine, and bilirubin will be absent in severe cases.
Neonatal Jaundice
Conjugating enzymes in the liver are often absent at birth. Hence raised serum level of
indirect (and total) bilirubin is to be expected, with a low level of direct bilirubin. The other
liver functions are normal. The indirect bilirubin level will rise for the first few days after
birth until the conjugating enzymes begin to synthesize. If the latter process is delayed
and the serum level of indirect bilirubin rises towards 20 mg/dl, an ultraviolet therapy or an
exchange blood transfusion should be carried out owing to the danger of deposition of the
insoluble unconjugated bilirubin in the basal ganglia of the brain leading to the condition
known as Kernicterus, and permanent Brain Damage.
10. Post-Hepatic Jaundice
C. Biliary duct
stone
Normal unconjugated
bilirubin (in blood)
conjugated bilirubin
(in blood)
Cholecystitis
Here, the bile duct is blocked. The indirect
bilirubin level is normal but conjugated bilirubin is
regurgitated into the blood and excreted into the
urine (raised conjugated and total bilirubin).
Enzymes will be regurgitated into the blood giving
raised levels. The other liver function tests
normal. If the bile ducts are obstructed, direct
bilirubin will build up, escape from the liver, and
end up in the blood. If the levels are high enough,
some of it will appear in the urine. Only direct
bilirubin appears in the urine. Increased direct
bilirubin usually means that the biliary (liver
secretion) ducts are obstructed. This test is useful
in determining if a patient has liver disease or a
blocked bile duct.
11. Principle
Bilirubin in serum is coupled with diazotized Sulfanilic acid to
form azobilirubin .
The water soluble conjugated bilirubin (direct bilirubin )reacts
easily with reagents such as diazotized sulphanilic acid .
while the water insoluble unconjugated bilirubin( indirect
bilirubin) requires a solubilising reagent, such as Caffeine, in
order to react with the diazotized sulphanilic acid.
In this experiment, the direct bilirubin is estimated in the
absence of the solubilising agent and then further bilirubin
estimatin in the presence of the solubilising agent will give the
total bilirubin level.
The indirect or unconjugated bilirubin is then found by
difference.
12. Method
DB
DT
TB
TT
0.20 ml
0.20 ml
0.20 ml
0.20 ml
Solution 1
-
(0.05 ml)
-
(0.05 ml)
Solution 2
Sodium nitrate
2.00 ml
2.00 ml
1.00 ml
1.00 ml
Solution 3/ NaCl
solution 0.9%
0.20 ml
0.20 ml
0.20 ml
0.20 ml
Sample
Mix, let stand for 5 min. at 20-25oC. Read absorbance
of test against blank (ADB) for direct only at 546 nm.
FOR total stand for 30 min at 20-25oC.
-
-
1.00 ml
1.00 ml
For total bilirubin
add solution 4
Mix and let stand for 15 min and read the
absorbance at 546 nm against blank (ATB).
Label 4 tubes as TT(total test), TC( total control), DT(direct test), DC(direct control).
13. Calculation
Concentration of direct bilirubin in mg/ml serum
= (abs. DT- abs. DB) X 14.4 = mg /dl
Normal range Up to: 0.25 mg/dl
Concentration of total bilirubin in mg/ml serum
= (abs. TT- abs. TB)X 10.8 = mg /dl
Normal range Up to 1 mg/dl
bilirubin comes from breakdown of heme by the RES (splenic, hepatic and marrow macrophages) 80% from RBC breakdown and 20% from other heme containing proteins. Within macrophages oxidised to biliverdin and then reduced to uncongulated bilirubin which is released into plasma and is water insoluble, transported bound to plasma proteins (albumin). This is then actively transported into hepatocytes, where it is conjugated mostly to glucoronic acid (by glucuronyl transferase congenital failure of which is Gilbert’s disease) and becomes water-soluble conjugated bilirubin which is concentrated and actively excreted into the bile canaliculi (failure of this is Dubin Johnson type hyperbilirubinaemia). Bilirubin is then secreted along with bile salts and sodium into the intestine (bile), where it is broken down to urobilinogen. 90% of urobilinogen is broken down in the gut to urobilin and stercobilin and excreted in stools, other 10% is re-absorbed. The reabsorbed urobilinogen is either recirculated into bile by liver or excreted in urine.
Therefore only conjugated bilirubin can be excreted in urine because it’s water-soluble. Therefore haemolytic jaundice is acholuric.
Van den Burgh reaction detects conjugated (direct) or unconjugated (indirect) bilirubin
Cholecystographic media compete with conjugated bilirubin for concentration and therefore will not be concentrated in the setting of excess bilirubin
In obstructive jaundice the pale stools are due to decreased bile pigments, whereas stools may be darker than usual in haemolytic jaundice due to excess stercobilinogen production
If liver function is impaired there will be decreased ability to re-excrete urobilinogen and stercobilinogen and more will appear in urine
Complete obstruction of biliary tree will lead to absence of urobilinogen from urine – prolonged absence indicates pancreatic head malignancy rather than stones because they will let some bile through
Therefore examination of the stools and testing urine for urobilinogen can help differentiate types of jaundice.
Bilirubin functions as an anti-oxidant
bilirubin comes from breakdown of haem by the RES (splenic, hepatic and marrow macrophages) 80% from RBC breakdown and 20% from other haem containing proteins. Within macrophages oxidised to biliverdin and then reduced to uncongulated bilirubin which is released into plasma and is water insoluble, transported bound to plasma proteins (albumin). This is then actively transported into hepatocytes, where it is conjugated mostly to glucoronic acid (by glucuronyl transferase congenital failure of which is Gilbert’s disease) and becomes water-soluble conjugated bilirubin which is concentrated and actively excreted into the bile canaliculi (failure of this is Dubin Johnson type hyperbilirubinaemia). Bilirubin is then secreted along with bile salts and sodium into the intestine (bile), where it is broken down to urobilinogen. 90% of urobilinogen is broken down in the gut to urobilin and stercobilin and excreted in stools, other 10% is re-absorbed. The reabsorbed urobilinogen is either recirculated into bile by liver or excreted in urine.
Therefore only conjugated bilirubin can be excreted in urine because it’s water-soluble. Therefore haemolytic jaundice is acholuric.
Van den Burgh reaction detects conjugated (direct) or unconjugated (indirect) bilirubin
Cholecystographic media compete with conjugated bilirubin for concentration and therefore will not be concentrated in the setting of excess bilirubin
In obstructive jaundice the pale stools are due to decreased bile pigments, whereas stools may be darker than usual in haemolytic jaundice due to excess stercobilinogen production
If liver function is impaired there will be decreased ability to re-excrete urobilinogen and stercobilinogen and more will appear in urine
Complete obstruction of biliary tree will lead to absence of urobilinogen from urine – prolonged absence indicates pancreatic head malignancy rather than stones because they will let some bile through
Therefore examination of the stools and testing urine for urobilinogen can help differentiate types of jaundice.
Bilirubin functions as an anti-oxidant
Pre-hepatic, hepatic and post-hepatic
Can usually determine type from history, exam, simple investigations- urine and blood tests.
Pitfalls:
some patients don’t fit just one type and have a combined picture
In the production of jaundice more than one mechanism may be involved
Increased use of pharmaceuticals which can cause any type of jaundice – account for up to 10% of pts presenting to hospital with jaundice
Pre-hepatic, hepatic and post-hepatic
Can usually determine type from history, exam, simple investigations- urine and blood tests.
Pitfalls:
some patients don’t fit just one type and have a combined picture
In the production of jaundice more than one mechanism may be involved
Increased use of pharmaceuticals which can cause any type of jaundice – account for up to 10% of pts presenting to hospital with jaundice
Pre-hepatic, hepatic and post-hepatic
Can usually determine type from history, exam, simple investigations- urine and blood tests.
Pitfalls:
some patients don’t fit just one type and have a combined picture
In the production of jaundice more than one mechanism may be involved
Increased use of pharmaceuticals which can cause any type of jaundice – account for up to 10% of pts presenting to hospital with jaundice